Table 2.
Treatment and post treatment outcomes
| Type of surgery | MIS (n = 40) | Open (n = 39) |
|---|---|---|
| ISR | 8 | 5 (2 patients beyond TME) |
| Prone APR | 1 | 2 |
| ELAPR | 7(3 beyond TME) | 18(6 beyond TME, 1 with i/l ILND) |
| AR | 24 | 9 (3 beyond TME) |
| AR + PLND + RPLND | 0 | 1 |
| Total Pelvic exenteration | 0 | 1 |
| Posterior exenteration | 0 | 3 |
| From HPR | ||
| Early T stage (pCR, pT1, pT2) | ||
| Mean DFS (months) | 34 | 28.53 |
| Late T stage (pT3, pT4) | ||
| Mean DFS | 24.86 | 22.50 |
| Early T stage (pCR, pT1, pT2) | ||
| Mean OS | 39.5 | 38.12 |
| Late T stage (pT3, pT4) | ||
| Mean OS | 28.95 | 32.6 |
| Overall | ||
| Mean DFS (months) | 29 | 25.8 |
| Overall | ||
| Mean OS (months) | 33.65 | 36.34 |
| Median duration of follow-up (months) | 30 | 32 |